Skip to content

Methyl 4-[(1R,2R,5S,8S,9R,10R,13S,14R,20S)-5-[2-(dimethylamino)ethylcarbamoyl]-1,2,14,18-tetramethyl-8-propan-2-yl-19-azahexacyclo[11.9.0.02,10.05,9.014,20.018,20]docosan-17-yl]benzoate

C41H63N3O3 — CID 145429330

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACmethyl 4-[(1R,2R,5S,8S,9R,10R,13S,14R,20S)-5-[2-(dimethylamino)ethylcarbamoyl]-1,2,14,18-tetramethyl-8-propan-2-yl-19-azahexacyclo[11.9.0.02,10.05,9.014,20.018,20]docosan-17-yl]benzoate
SMILESCOC(=O)c1ccc(C2CC[C@]3(C)[C@H]4CC[C@@H]5[C@H]6[C@H](C(C)C)CC[C@]6(C(=O)NCCN(C)C)CC[C@@]5(C)[C@]4(C)CC[C@]34NC24C)cc1
InChIInChI=1S/C41H63N3O3/c1-26(2)29-16-19-40(35(46)42-24-25-44(7)8)22-20-36(3)31(33(29)40)14-15-32-37(36,4)21-23-41-38(32,5)18-17-30(39(41,6)43-41)27-10-12-28(13-11-27)34(45)47-9/h10-13,26,29-33,43H,14-25H2,1-9H3,(H,42,46)/t29-,30?,31+,32-,33+,36+,37+,38+,39?,40-,41-/m0/s1
InChIKeyMOWJLZYKCLMLFS-LUWHAGJRSA-N
MW645.97 g/mol
LogP7.43
Rot. Bonds7

About Methyl 4-[(1R,2R,5S,8S,9R,10R,13S,14R,20S)-5-[2-(dimethylamino)ethylcarbamoyl]-1,2,14,18-tetramethyl-8-propan-2-yl-19-azahexacyclo[11.9.0.02,10.05,9.014,20.018,20]docosan-17-yl]benzoate

Methyl 4-[(1R,2R,5S,8S,9R,10R,13S,14R,20S)-5-[2-(dimethylamino)ethylcarbamoyl]-1,2,14,18-tetramethyl-8-propan-2-yl-19-azahexacyclo[11.9.0.02,10.05,9.014,20.018,20]docosan-17-yl]benzoate (PubChem CID 145429330) has the molecular formula C41H63N3O3 and a molecular weight of 645.97 g/mol. Its IUPAC name is methyl 4-[(1R,2R,5S,8S,9R,10R,13S,14R,20S)-5-[2-(dimethylamino)ethylcarbamoyl]-1,2,14,18-tetramethyl-8-propan-2-yl-19-azahexacyclo[11.9.0.02,10.05,9.014,20.018,20]docosan-17-yl]benzoate.

Molecular Properties

Compound NameMethyl 4-[(1R,2R,5S,8S,9R,10R,13S,14R,20S)-5-[2-(dimethylamino)ethylcarbamoyl]-1,2,14,18-tetramethyl-8-propan-2-yl-19-azahexacyclo[11.9.0.02,10.05,9.014,20.018,20]docosan-17-yl]benzoate
PubChem CID145429330
Molecular FormulaC41H63N3O3
Molecular Weight645.97 g/mol
Exact Mass645.49
IUPAC Namemethyl 4-[(1R,2R,5S,8S,9R,10R,13S,14R,20S)-5-[2-(dimethylamino)ethylcarbamoyl]-1,2,14,18-tetramethyl-8-propan-2-yl-19-azahexacyclo[11.9.0.02,10.05,9.014,20.018,20]docosan-17-yl]benzoate
SMILESCOC(=O)c1ccc(C2CC[C@]3(C)[C@H]4CC[C@@H]5[C@H]6[C@H](C(C)C)CC[C@]6(C(=O)NCCN(C)C)CC[C@@]5(C)[C@]4(C)CC[C@]34NC24C)cc1
InChIInChI=1S/C41H63N3O3/c1-26(2)29-16-19-40(35(46)42-24-25-44(7)8)22-20-36(3)31(33(29)40)14-15-32-37(36,4)21-23-41-38(32,5)18-17-30(39(41,6)43-41)27-10-12-28(13-11-27)34(45)47-9/h10-13,26,29-33,43H,14-25H2,1-9H3,(H,42,46)/t29-,30?,31+,32-,33+,36+,37+,38+,39?,40-,41-/m0/s1
InChIKeyMOWJLZYKCLMLFS-LUWHAGJRSA-N
XLogP7.43
TPSA80.58 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds7
Heavy Atoms47
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500645.97
LogP ≤ 57.43
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'}

Analyze Methyl 4-[(1R,2R,5S,8S,9R,10R,13S,14R,20S)-5-[2-(dimethylamino)ethylcarbamoyl]-1,2,14,18-tetramethyl-8-propan-2-yl-19-azahexacyclo[11.9.0.02,10.05,9.014,20.018,20]docosan-17-yl]benzoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Methyl 4-[(1R,2R,5S,8S,9R,10R,13S,14R,20S)-5-[2-(dimethylamino)ethylcarbamoyl]-1,2,14,18-tetramethyl-8-propan-2-yl-19-azahexacyclo[11.9.0.02,10.05,9.014,20.018,20]docosan-17-yl]benzoate?
The IUPAC name of Methyl 4-[(1R,2R,5S,8S,9R,10R,13S,14R,20S)-5-[2-(dimethylamino)ethylcarbamoyl]-1,2,14,18-tetramethyl-8-propan-2-yl-19-azahexacyclo[11.9.0.02,10.05,9.014,20.018,20]docosan-17-yl]benzoate (CID 145429330) is methyl 4-[(1R,2R,5S,8S,9R,10R,13S,14R,20S)-5-[2-(dimethylamino)ethylcarbamoyl]-1,2,14,18-tetramethyl-8-propan-2-yl-19-azahexacyclo[11.9.0.02,10.05,9.014,20.018,20]docosan-17-yl]benzoate.
What is the SMILES notation for Methyl 4-[(1R,2R,5S,8S,9R,10R,13S,14R,20S)-5-[2-(dimethylamino)ethylcarbamoyl]-1,2,14,18-tetramethyl-8-propan-2-yl-19-azahexacyclo[11.9.0.02,10.05,9.014,20.018,20]docosan-17-yl]benzoate?
The canonical SMILES for Methyl 4-[(1R,2R,5S,8S,9R,10R,13S,14R,20S)-5-[2-(dimethylamino)ethylcarbamoyl]-1,2,14,18-tetramethyl-8-propan-2-yl-19-azahexacyclo[11.9.0.02,10.05,9.014,20.018,20]docosan-17-yl]benzoate is COC(=O)c1ccc(C2CC[C@]3(C)[C@H]4CC[C@@H]5[C@H]6[C@H](C(C)C)CC[C@]6(C(=O)NCCN(C)C)CC[C@@]5(C)[C@]4(C)CC[C@]34NC24C)cc1.
What is the InChIKey of Methyl 4-[(1R,2R,5S,8S,9R,10R,13S,14R,20S)-5-[2-(dimethylamino)ethylcarbamoyl]-1,2,14,18-tetramethyl-8-propan-2-yl-19-azahexacyclo[11.9.0.02,10.05,9.014,20.018,20]docosan-17-yl]benzoate?
The InChIKey is MOWJLZYKCLMLFS-LUWHAGJRSA-N. The full InChI is InChI=1S/C41H63N3O3/c1-26(2)29-16-19-40(35(46)42-24-25-44(7)8)22-20-36(3)31(33(29)40)14-15-32-37(36,4)21-23-41-38(32,5)18-17-30(39(41,6)43-41)27-10-12-28(13-11-27)34(45)47-9/h10-13,26,29-33,43H,14-25H2,1-9H3,(H,42,46)/t29-,30?,31+,32-,33+,36+,37+,38+,39?,40-,41-/m0/s1.
What are the key properties of Methyl 4-[(1R,2R,5S,8S,9R,10R,13S,14R,20S)-5-[2-(dimethylamino)ethylcarbamoyl]-1,2,14,18-tetramethyl-8-propan-2-yl-19-azahexacyclo[11.9.0.02,10.05,9.014,20.018,20]docosan-17-yl]benzoate?
Methyl 4-[(1R,2R,5S,8S,9R,10R,13S,14R,20S)-5-[2-(dimethylamino)ethylcarbamoyl]-1,2,14,18-tetramethyl-8-propan-2-yl-19-azahexacyclo[11.9.0.02,10.05,9.014,20.018,20]docosan-17-yl]benzoate has a molecular weight of 645.97 g/mol, XLogP of 7.43, 7 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for Methyl 4-[(1R,2R,5S,8S,9R,10R,13S,14R,20S)-5-[2-(dimethylamino)ethylcarbamoyl]-1,2,14,18-tetramethyl-8-propan-2-yl-19-azahexacyclo[11.9.0.02,10.05,9.014,20.018,20]docosan-17-yl]benzoate is sourced from PubChem (CID 145429330), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.